dc.contributor.author | Pineda Martos, Carmen María | |
dc.contributor.author | Raya Bermúdez, Ana Isabel | |
dc.contributor.author | Morgaz Rodríguez, Juan | |
dc.contributor.author | Sánchez-Céspedes, Raquel | |
dc.contributor.author | Millán, Yolanda | |
dc.contributor.author | Aguilera Tejero, Escolástico | |
dc.contributor.author | López Villalba, Ignacio | |
dc.date.accessioned | 2025-01-07T18:26:04Z | |
dc.date.available | 2025-01-07T18:26:04Z | |
dc.date.issued | 2024 | |
dc.identifier.issn | 0891-6640 | |
dc.identifier.uri | http://hdl.handle.net/10396/30524 | |
dc.description.abstract | Background: Little information exists about vitamin D status in bitches with mammary tumors.
Objectives: To determine whether low plasma vitamin D concentrations are found in bitches with mammary tumors.
Animals: Eighty-five client-owned bitches with mammary tumors (n = 21 benign, n = 64 malignant) and 39 age-matched healthy bitches.
Methods: Case-control study. Plasma ionized and total calcium, phosphorus, magnesium, urea, creatinine, albumin, total proteins, alanine aminotransferase, alkaline phosphatase, parathyroid hormone (PTH), calcitriol (1,25-dihydroxyvitamin D), and 25-hydroxyvitamin D concentrations were measured in all bitches at the time of clinical diagnosis and before any treatments. Statistical analysis was performed to compare variables among groups (control, benign, and malignant).
Results: No significant differences were found when plasma 25-hydroxyvitamin D concentrations in bitches with malignant (148.9 [59.9] ng/mL) and benign mammary tumors (150.1 [122.3] ng/mL) were compared with control group (129.9 [54.5] ng/mL). Parathyroid hormone was significantly higher in bitches with malignant (19.9 [20.5] pg/mL), and benign mammary tumors (14.6 [14.9] pg/mL) compared with control group (7.5 [7.5] pg/mL; P < .01). Only the presence of mammary tumors (P < .01) and age (P = .04; adjusted R2 = .22) was significant in predicting PTH.
Conclusions: Bitches with mammary tumors do not have low 25-hydroxyvitamin D concentrations thus vitamin D supplementation is unlikely to be useful for prevention of mammary tumors in bitches. | es_ES |
dc.format.mimetype | application/pdf | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Wiley | es_ES |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/ | es_ES |
dc.source | Pineda, C., Raya, A. I., Morgaz, J., Sánchez‐Céspedes, R., Millán, Y., Aguilera‐Tejero, E., & López, I. (2024). Vitamin D status in female dogs with mammary gland tumors. Journal Of Veterinary Internal Medicine, 38(4), 2257-2264. https://doi.org/10.1111/jvim.17137 | es_ES |
dc.subject | 1,25‐dihydroxyvitamin D | es_ES |
dc.subject | 25‐hydroxyvitamin D | es_ES |
dc.subject | Canine | es_ES |
dc.subject | Mammary cancer | es_ES |
dc.subject | Mineral metabolism | es_ES |
dc.title | Vitamin D status in female dogs with mammary gland tumors | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | https://dx.doi.org/10.1111/jvim.17137 | es_ES |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es_ES |